Chronic obstructive pulmonary disease phenotypes: imprint on pharmacological and non-pharmacological therapy

Pharmacological treatment of chronic obstructive pulmonary disease

None of the drugs currently available for chronic obstructive pulmonary disease (COPD) are able to reduce the progressive decline in lung function which is the hallmark of this disease. Smoking cessation is the only intervention that has proved effective. The current pharmacological treatment of COPD is symptomatic and is mainly based on bronchodilators, such as selective beta2-adrenergic agoni...

Chronic obstructive pulmonary disease 8: non-pharmacological management of COPD.

The role of smoking cessation and the use of measures to reduce the disability associated with COPD are reviewed. The political profile of patients with COPD is increasing as patient support groups develop the confidence to campaign for better services.

Non-Pharmacological Management of Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is the third leading cause of morbidity and mortality globally, contributing to a substantialuse of resources. According to World Health Organization estimates, 65 million people have moderate to severe COPD. The conditionis also recognised as a systemic disease with extrapulmonary manifestations, such as peripheral muscle dysfunction, malnutrition a...

Statins and Pulmonary Hypertension in Chronic Obstructive Lung Disease

Chronic obstructive lung disease (COPD) is a chronic multisystem disease with a considerable burden. One of its most common complications is pulmonary artery hypertension (PAH). It has been demonstrated that the development of PAH is correlated with decreased quality of life and survival. Different medications have been proposed for the treatment of PAH, among which one can name statins. Howeve...

ABC of chronic obstructive pulmonary disease.Non-pharmacological management.